The Role of the Pentose Phosphate Pathway in Diabetes and Cancer

被引：290

作者：

Ge, Tongxin ^{[1
]}

Yang, Jiawen ^{[1
]}

Zhou, Shihui ^{[1
]}

Wang, Yuchen ^{[1
]}

Li, Yakui ^{[1
]}

Tong, Xuemei ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Key Lab Cell Differentiat & Apoptosis, Dept Biochem & Mol Cell Biol,Minist Educ,Sch Med, Shanghai, Peoples R China

来源：

FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷

基金：

国家重点研发计划; 中国国家自然科学基金;

关键词：

the pentose phosphate pathway; metabolism; obesity; diabetes; cancer; ACTIVATES 6-PHOSPHOGLUCONATE DEHYDROGENASE; ANABOLIC GLUCOSE-METABOLISM; ADIPOSE-TISSUE INFLAMMATION; HEPATIC INSULIN-RESISTANCE; CELL-CYCLE PROGRESSION; HIGH-DOSE THIAMINE; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; PROTEOMIC ANALYSIS; SKELETAL-MUSCLE;

D O I：

10.3389/fendo.2020.00365

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The pentose phosphate pathway (PPP) branches from glucose 6-phosphate (G6P), produces NADPH and ribose 5-phosphate (R5P), and shunts carbons back to the glycolytic or gluconeogenic pathway. The PPP has been demonstrated to be a major regulator for cellular reduction-oxidation (redox) homeostasis and biosynthesis. Enzymes in the PPP are reported to play important roles in many human diseases. In this review, we will discuss the role of the PPP in type 2 diabetes and cancer.

引用

页数：11

共 123 条

[1] INSULIN-SECRETION IN PATIENTS DEFICIENT IN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE [J].

ALEGRE, SM ;

SAAD, STO ;

DELATRE, E ;

SAAD, MJA .

HORMONE AND METABOLIC RESEARCH, 1991, 23 (04) :171-173

[2] A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy [J].

Alkhalaf, Alaa ;

Klooster, Astrid ;

van Oeveren, Willem ;

Achenbach, Ulrike ;

Kleefstra, Nanne ;

Slingerland, Robbert J. ;

Mijnhout, G. Sophie ;

Bilo, Henk J. G. ;

Gans, Reinold O. B. ;

Navis, Gerjan J. ;

Bakker, Stephan J. L. .

DIABETES CARE, 2010, 33 (07) :1598-1601

[3] Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer [J].

Andersen, Dana K. ;

Korc, Murray ;

Petersen, Gloria M. ;

Eibl, Guido ;

Li, Donghui ;

Rickels, Michael R. ;

Chari, Suresh T. ;

Abbruzzese, James L. .

DIABETES, 2017, 66 (05) :1103-1110

[4] The differential role of reactive oxygen species in early and late stages of cancer [J].

Assi, Mohamad .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2017, 313 (06) :R646-R653

[5] Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine [J].

Babaei-Jadidi, R ;

Karachalias, N ;

Ahmed, N ;

Battah, S ;

Thornalley, PJ .

DIABETES, 2003, 52 (08) :2110-2120

[6] Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome [J].

Benito, Adrian ;

Polat, Ibrahim H. ;

Noe, Veronique ;

Ciudad, Carlos J. ;

Marin, Silvia ;

Cascante, Marta .

ONCOTARGET, 2017, 8 (63) :106693-106706

[7] TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].

Bensaad, Karim ;

Tsuruta, Atsushi ;

Selak, Mary A. ;

Calvo Vidal, M. Nieves ;

Nakano, Katsunori ;

Bartrons, Ramon ;

Gottlieb, Eyal ;

Vousden, Karen H. .

CELL, 2006, 126 (01) :107-120

[8]

Bhanot H, 2017, ONCOTARGET, V8, P67639, DOI 10.18632/oncotarget.18797

[9] Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging [J].

Bradshaw, Patrick C. .

NUTRIENTS, 2019, 11 (03)

[10] Targeting macrophages: therapeutic approaches in cancer [J].

Cassetta, Luca ;

Pollard, Jeffrey W. .

NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904

← 1 2 3 4 5 6 7 8 9 10 →